FORMULATION OF GLICLAZIDE USING SELF-NANO-EMULSIFICATION TECHNOLOGY

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2018, Vol 5, Issue 5

Abstract

Self-nano-emulsifying drugs delivery systems present an effective drug delivery system for the formulation of a hydrophobic drug with poor water-solubility. Gliclazide is practically insoluble in water and is amenable for self-nano-emulsifying drug delivery. This study aimed to develop a formulation of gliclazide using Cremophor RH 40 and Tween 20 with capryol 90 as oil vehicle. A solubility study, particle size analysis and ternary phase diagram were developed to select the optimal formulation to take forward to stability testing. Accelerated physical stability and self-emulsification studies were performed. They were also compared for globule size, transmittance, polydispersity index and zeta potential. The solubility was greatest in Capryol 90 64.86 mg/mL, Cremophor RH 40 44.98 mg/mL, PEG 400 105.66 mg/mL, and Tween 20 86.83 mg/mL. The construction of the ternary phase diagram in the formulation using cremophor 40 as surfactant has good characteristics and wide area in nano-emulsifying formation than Tween 20. Gliclazide can be formulated and exhibits good stability in a self-nano-emulsifying drug delivery system.

Authors and Affiliations

Hana Morrissey

Keywords

Related Articles

EVALUATION OF THE POSSIBLE RENOPROTECTIVE EFFECT AND ANTIOXIDANT ACTIVITY OF MIRABEGRON ON GENTAMICIN-INDUCED NEPHROTOXICITY IN RATS

Introduction: Mirabegron is a novel β3-adrenergic receptor agonist that recently approved for the management of overactive urinary bladder disease. Reactive oxygen species (ROS) have a major role in the pathogenesis of g...

POTENTIAL DRUG INTERACTIONS IN PRESCRIPTION OF HEART FAILURE PATIENTS ASSISTED IN A PRIMARY PUBLIC HEALTH UNIT IN MARINGÁ, PARANÁ, BRAZIL

Purpose: The aim of this study was to detect probable drug interactions from elderly patients with heart failure in a primary health care. Methods: A cross-sectional study involving standardized of Electronic Health Reco...

SAFETY AND EFFICACY OF COMBINATION OF MONTELUKAST AND LEVOCETRIZINE IN THE SYMPTOMATIC TREATMENT OF ALLERGIC RHINITIS AND ASTHMA: PHASE IV CLINICAL STUDY

Introduction- Allergic rhinitis (AR) and allergic asthma are caused by an IgE-mediated inflammatory reaction and treatment of AR symptoms requires a stepwise approach depending on the severity and duration of symptoms. A...

OVERVIEW ON MANAGEMENT OF HEPATIC ENCEPHALOPATHY

Minimal hepatic encephalopathy (MHE) is a neurocognitive dysfunction that is present in the majority of patients with cirrhosis. MHE has a characteristic cognitive profile that cannot be diagnosed clinically. This cognit...

ACHIEVING AND PROMOTING HEALTHY LIFESTYLE BY SELF-MONITORING HABIT

India is battling a full-blown health crisis. Lancet study should be treated as a warning to our policymakers. Research reveals a dangerously rapid epidemiological transition and a rising burden of non-communicable disea...

Download PDF file
  • EP ID EP635783
  • DOI -
  • Views 177
  • Downloads 0

How To Cite

Hana Morrissey (2018). FORMULATION OF GLICLAZIDE USING SELF-NANO-EMULSIFICATION TECHNOLOGY. European Journal of Biomedical and Pharmaceutical Sciences, 5(5), 29-39. https://europub.co.uk/articles/-A-635783